Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis

被引:18
|
作者
Xu, Lei [1 ]
Yang, Chung S. [2 ]
Liu, Yanan [1 ]
Zhang, Xin [1 ]
机构
[1] Ningbo Univ, Dept Food Sci & Engn, Ningbo, Peoples R China
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Chem Biol, Piscataway, NJ 08854 USA
关键词
COVID-19; gut microbiota; probiotics; gut-lung axis; prebiotics; CHAIN FATTY-ACIDS; DIETARY FIBER; INTESTINAL MICROBIOTA; GREEN TEA; INFLAMMATION; INFECTION; POLYPHENOLS; MODULATION; DYSBIOSIS; IMMUNITY;
D O I
10.3389/fphar.2022.895193
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Coronavirus disease 2019 (COVID-19) can disrupt the gut microbiota balance, and patients usually have intestinal disorders. The intestine is the largest immune organ of the human body, and gut microbes can affect the immune function of the lungs through the gut-lung axis. Many lines of evidence support the role of beneficial bacteria in enhancing human immunity, preventing pathogen colonization, and thereby reducing the incidence and severity of infection. In this article, we review the possible approach of modulating microbiota to help prevent and treat respiratory tract infections, including COVID-19, and discuss the possibility of using probiotics and prebiotics for this purpose. We also discuss the mechanism by which intestinal micro-flora regulate immunity and the effects of probiotics on the intestinal micro-ecological balance. Based on this understanding, we propose the use of probiotics and prebiotics to modulate gut microbiota for the prevention or alleviation of COVID-19 through the gut-lung axis.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The impact of probiotics on interactions within the microbiota-gut-lung triad in COVID-19
    Mulak, Agata
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2021, 72 (04) : 577 - 578
  • [22] The Microbiota and Equine Asthma: An Integrative View of the Gut-Lung Axis
    Leduc, Laurence
    Costa, Marcio
    Leclere, Mathilde
    ANIMALS, 2024, 14 (02):
  • [23] Emerging pathogenic links between microbiota and the gut-lung axis
    Budden, Kurtis F.
    Gellatly, Shaan L.
    Wood, David L. A.
    Cooper, Matthew A.
    Morrison, Mark
    Hugenholtz, Philip
    Hansbro, Philip M.
    NATURE REVIEWS MICROBIOLOGY, 2017, 15 (01) : 55 - 63
  • [24] Potential Application of Tea Polyphenols to the Prevention of COVID-19 Infection: Based on the Gut-Lung Axis
    Xu, Lei
    Ho, Chi-Tang
    Liu, Yanan
    Wu, Zufang
    Zhang, Xin
    FRONTIERS IN NUTRITION, 2022, 9
  • [25] Gut-Lung Microbiota Characterization in Patients with Non-Small Cell Lung Carcinoma and COVID-19 Coinfection
    Vakili, Bahareh
    Shoaei, Parisa
    Shahzamani, Kiana
    Siadat, Seyed Davar
    Shojaei, Hasan
    Esfandiari, Zahra
    Nasri, Elahe
    Shabani, Shiva
    Moghadam, Ali Zamani
    Ataei, Behrooz
    ARCHIVES OF IRANIAN MEDICINE, 2024, 27 (02) : 62 - 71
  • [26] Genetic Insights into the Gut-Lung Axis: Mendelian Randomization Analysis on Gut Microbiota, Lung Function, and COPD
    Cheng, Zi-Xuan
    Hua, Jian-Lan
    Jie, Zhi-Jun
    Li, Xing-Jing
    Zhang, Jing
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 643 - 653
  • [27] Gut-lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
    Zhang, Huaiyuan
    Xu, Ziyuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Diet, Probiotics and Their Impact on the Gut Microbiota during the COVID-19 Pandemic
    Jabczyk, Marzena
    Nowak, Justyna
    Hudzik, Bartosz
    Zubelewicz-Szkodzinska, Barbara
    NUTRIENTS, 2021, 13 (09)
  • [29] Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis
    Willis, Kent A.
    Stewart, Justin D.
    Ambalavanan, Namasivayam
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (04) : L710 - L716
  • [30] The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
    Quan, Yunyun
    Yin, Zhujun
    Chen, Shilong
    Lang, Jirui
    Han, Liyang
    Yi, Jing
    Zhang, Lu
    Yue, Qianhua
    Tian, Weiwei
    Chen, Ping
    Du, Shenglin
    Wang, Jianbo
    Dai, Ying
    Hua, Hua
    Zeng, Jin
    Li, Li
    Zhao, Junning
    FRONTIERS IN PHARMACOLOGY, 2022, 13